• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于慢性完全闭塞病变介入治疗的“单臂双腔”技术

"Single Arm-Double Access" for CTO Intervention.

作者信息

Koutouzis Michael, Kontopodis Eleftherios, Tassopoulos Andreas, Tsiafoutis Ioannis, Oikonomidis Nikolaos, Lazaris Efstathios

机构信息

2nd Department of Cardiology, Hellenic Red Cross Hospital, Athanasaki 1, GR 11526, Athens, Greece.

出版信息

J Invasive Cardiol. 2019 Jan;31(1):E7. doi: 10.25270/jic/19.3101.E7.

DOI:10.25270/jic/19.3101.E7
PMID:30611129
Abstract

To our knowledge, this is the first reported case of a dual-access approach for CTO intervention using transradial and ipsilateral transulnar access. Although retrograde CTO intervention is a challenging procedure, a single arm-double access approach seems to be a feasible alternative that may be useful in patients with limited access-site availability.

摘要

据我们所知,这是首例报道的采用经桡动脉和同侧经尺动脉入路进行慢性完全闭塞病变(CTO)介入治疗的双入路方法。尽管逆向CTO介入治疗是一项具有挑战性的操作,但单臂双入路方法似乎是一种可行的替代方案,可能对入路部位选择有限的患者有用。

相似文献

1
"Single Arm-Double Access" for CTO Intervention.用于慢性完全闭塞病变介入治疗的“单臂双腔”技术
J Invasive Cardiol. 2019 Jan;31(1):E7. doi: 10.25270/jic/19.3101.E7.
2
Safety and feasibility of transulnar catheterization when ipsilateral radial access is not available.当同侧桡动脉入路不可用时,经尺动脉入路的安全性和可行性。
Catheter Cardiovasc Interv. 2014 Jan 1;83(1):E51-60. doi: 10.1002/ccd.25123. Epub 2013 Aug 5.
3
Fully Transradial Versus Transfemoral Approach for Percutaneous Intervention of Coronary Chronic Total Occlusions Applying the Hybrid Algorithm: Insights From RECHARGE Registry.经桡动脉与经股动脉途径行冠状动脉慢性完全闭塞病变介入治疗的杂交算法:RECHARGE 注册研究的结果
Circ Cardiovasc Interv. 2017 Sep;10(9). doi: 10.1161/CIRCINTERVENTIONS.117.005255.
4
Transulnar compared with transradial artery approach as a default strategy for coronary procedures: a randomized trial. The Transulnar or Transradial Instead of Coronary Transfemoral Angiographies Study (the AURA of ARTEMIS Study).经桡动脉入路与经尺动脉入路作为冠状动脉介入治疗的默认策略比较:一项随机试验。经桡动脉或经尺动脉入路而非经股动脉冠状动脉造影术研究(ARTEMIS 研究的 AURA)。
Circ Cardiovasc Interv. 2013 Jun;6(3):252-61. doi: 10.1161/CIRCINTERVENTIONS.112.000150. Epub 2013 Jun 4.
5
Alternative (Transulnar or Distal Radial) Arterial Access for Chronic Total Occlusion Percutaneous Coronary Intervention (Subanalysis from the Minimalistic Hybrid Approach Algorithm Registry).慢性完全闭塞性经皮冠状动脉介入治疗的替代(经尺动脉或桡动脉远端)动脉入路(来自简约混合方法算法注册研究的亚分析)
Am J Cardiol. 2023 Aug 1;200:57-65. doi: 10.1016/j.amjcard.2023.05.005. Epub 2023 Jun 9.
6
Bilateral percutaneous ulnar artery approach for retrograde chronic total occlusion intervention.
Int Heart J. 2010 Mar;51(2):137-40. doi: 10.1536/ihj.51.137.
7
Feasibility of 5 Fr Contralateral Radial Access for Hybrid Chronic Total Occlusion Percutaneous Coronary Intervention: Experience From a Single Tertiary Center in the United Kingdom.5F对侧桡动脉入路用于杂交慢性完全闭塞经皮冠状动脉介入治疗的可行性:来自英国一家三级中心的经验
J Invasive Cardiol. 2019 Jun;31(6):159-165. doi: 10.25270/jic/18.00138. Epub 2019 Feb 15.
8
Feasibility and Safety of Ipsilateral Ulnar Access in Cases of Impossibility or Failure of Radial Access for Coronary Angiography or Percutaneous Coronary Intervention.尺侧入路在桡动脉入路行冠状动脉造影或经皮冠状动脉介入治疗无法或失败时的可行性和安全性。
J Invasive Cardiol. 2022 Feb;34(2):E92-E97. doi: 10.25270/jic/21.00138. Epub 2022 Jan 16.
9
An update on radial approach for percutaneous coronary intervention in patients with chronic total occlusion.慢性完全闭塞患者经皮冠状动脉介入治疗桡动脉途径的最新进展。
Minerva Cardioangiol. 2017 Apr;65(2):140-147. doi: 10.23736/S0026-4725.16.04283-3. Epub 2016 Nov 15.
10
Transulnar approach as an alternative access site for coronary invasive procedures after transradial approach failure.经桡动脉途径失败后,经尺动脉入路作为冠状动脉介入治疗的一种替代入路方法。
Am Heart J. 2012 Oct;164(4):462-7. doi: 10.1016/j.ahj.2012.08.001.